AU589148B2 - Medicament for the treatment of acquired immune deficiency syndrome and corresponding pharmaceutical compositions and method of treatment - Google Patents

Medicament for the treatment of acquired immune deficiency syndrome and corresponding pharmaceutical compositions and method of treatment

Info

Publication number
AU589148B2
AU589148B2 AU50580/85A AU5058085A AU589148B2 AU 589148 B2 AU589148 B2 AU 589148B2 AU 50580/85 A AU50580/85 A AU 50580/85A AU 5058085 A AU5058085 A AU 5058085A AU 589148 B2 AU589148 B2 AU 589148B2
Authority
AU
Australia
Prior art keywords
treatment
immune deficiency
deficiency syndrome
acquired immune
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU50580/85A
Other versions
AU5058085A (en
Inventor
Francoise Barre-Sinoussi
Jean-Claude Chermann
Dominique Dormont
Luc Montagnier
Willy Rozenbaum
Bruno Spire
Etienne Vilmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of AU5058085A publication Critical patent/AU5058085A/en
Application granted granted Critical
Publication of AU589148B2 publication Critical patent/AU589148B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1. Use of an alkali metal salt and/or alkaline earth metal salt and/or ammonium salt of the heteropolyanion (NaSb9 W21 O86)**18-, optionally in a hydrated form, for manufacturing a medicinal composition intended for the treatment of acquired immune deficiency syndrome (AIDS) and similar syndromes.
AU50580/85A 1984-12-03 1985-12-02 Medicament for the treatment of acquired immune deficiency syndrome and corresponding pharmaceutical compositions and method of treatment Ceased AU589148B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67824084A 1984-12-03 1984-12-03
US678240 1984-12-03

Publications (2)

Publication Number Publication Date
AU5058085A AU5058085A (en) 1986-07-17
AU589148B2 true AU589148B2 (en) 1989-10-05

Family

ID=24721989

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50580/85A Ceased AU589148B2 (en) 1984-12-03 1985-12-02 Medicament for the treatment of acquired immune deficiency syndrome and corresponding pharmaceutical compositions and method of treatment

Country Status (6)

Country Link
EP (1) EP0185584B1 (en)
JP (1) JPS61227525A (en)
AT (1) ATE37142T1 (en)
AU (1) AU589148B2 (en)
DE (2) DE3542165A1 (en)
IL (1) IL77188A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332940C (en) * 1986-08-07 1994-11-08 Henrich Hasko Paradies N-alkylated quaternary nitrogen-containing heterocycles
JP2707252B2 (en) * 1987-08-03 1998-01-28 利博 山瀬 Antiviral agent
WO1990006756A1 (en) * 1988-12-16 1990-06-28 Terumo Kabushiki Kaisha Antiviral agent
JP2993674B2 (en) * 1989-02-01 1999-12-20 利博 山瀬 Anti-acquired immunodeficiency syndrome virus agent
JPH0334931A (en) * 1989-06-30 1991-02-14 Hokkaido Togyo Kk Anti-retrovirus agent
DE4302053C1 (en) * 1993-01-26 1994-06-30 Gunther Dr Kuemel Synergistic compsn. for preventing HIV infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2245374B1 (en) * 1973-07-27 1977-02-25 Anvar
GB1573002A (en) * 1975-12-10 1980-08-13 Anvar Antiviral agent
FR2334366A2 (en) * 1975-12-10 1977-07-08 Anvar 9-Antimonic-(21)-tungsto-sodate heteropolyanions - pref. as the ammonium or metal salts are antivirals synergistic with interferon, active against leukaemia and sarcoma viruses
FR2372633A2 (en) * 1976-12-03 1978-06-30 Anvar COMPOUND OF HETEROPOLYANIONS CONTAINING TUNGSTENE COMBINED WITH ANTIMONY, THEIR OBTAINING AND THEIR APPLICATIONS

Also Published As

Publication number Publication date
DE3542165A1 (en) 1986-07-10
EP0185584B1 (en) 1988-09-14
DE3564907D1 (en) 1988-10-20
IL77188A0 (en) 1986-04-29
JPS61227525A (en) 1986-10-09
AU5058085A (en) 1986-07-17
JPH0262533B2 (en) 1990-12-26
ATE37142T1 (en) 1988-09-15
EP0185584A1 (en) 1986-06-25
IL77188A (en) 1989-03-31

Similar Documents

Publication Publication Date Title
DE3469342D1 (en) Pharmaceutical composition on the basis of valproic acid, and its manufacturing process
IL74882A0 (en) Naphthyridine-,quinoline-and benzoxazine-carboxylic acids and derivatives thereof,their manufacture and pharmaceutical compositions containing them
AU8171282A (en) 5 oxo-thiazolo(3,2-a)azepine-3-carboxylic acids
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA881764B (en) Thiazole derivatives active on the cholinerigic system,process for obtention and pharmaceutical compositions
AU8188087A (en) Variants of hirudin, their use and their preparation
AU589148B2 (en) Medicament for the treatment of acquired immune deficiency syndrome and corresponding pharmaceutical compositions and method of treatment
AU1463888A (en) Nitrification-inhibiting agent
AU4434389A (en) Aqueous oral pharmaceutical preparation of diclofenac
ZA858195B (en) 1,2,4-triazolo-carbamates and the acid addition salts thereof,processes for preparing them and pharmaceutical compositions
EP0107693A4 (en) 2,3,4-trinor-1,5-inter-m-phenylene-prostacyclin-i2 analogues, process for the preparation thereof and pharmaceutical compositions containing the same.
IL64859A (en) 7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives,their preparation and pharmaceutical compositions comprising them
ZA834409B (en) 1,4-dihydropyridine derivatives in optically active or in racemate form and their production and pharmaceutical compositions
AU3454984A (en) 1,z-dithiolanes and pharmaceutical compositions
EP0246861A3 (en) Pharmaceutical composition based on crotoxine, process for preparing the active component and the pharmaceutical composition
EP0084190A3 (en) Medicinal composition, package and method of making the composition
IL71905A (en) 3-alkyl bicyclo(3.2.1)octane-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL90191A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
PT86665A (en) PROCESS FOR THE PREPARATION OF 14.15-SUBSTITUTED LANOSTEROLS AND OF HYPOCHOLESTEROLEMIC COMPOSITIONS CONTAINING THE SAME
EP0038153A3 (en) Modified allergens
NZ223138A (en) 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives and pharmaceutical compositions
ES8401320A1 (en) Antibronchospastic water-soluble pharmaceutical compositions
IL74207A (en) Pteridine derivatives,process for the preparation thereof,and pharmaceutical compositions containing the same
EP0347459A4 (en) Cephalosporin compounds or their salts, process for their preparation, and pharmaceutical compositions.
EP0149327A3 (en) A prostaglandin salt and compositions containing it